Baxter PE Ratio 2010-2025 | BAX

Current and historical p/e ratio for Baxter (BAX) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Baxter PE ratio as of June 10, 2025 is 12.15.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Baxter PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-06-10 31.72 0.00
2025-03-31 34.04 $-1.10 0.00
2024-12-31 28.86 $-1.28 0.00
2024-09-30 37.39 $0.20 186.93
2024-06-30 32.68 $4.86 6.73
2024-03-31 41.40 $5.20 7.96
2023-12-31 37.19 $5.22 7.12
2023-09-30 36.01 $5.10 7.06
2023-06-30 43.17 $-5.66 0.00
2023-03-31 38.16 $-4.88 0.00
2022-12-31 47.62 $-4.83 0.00
2022-09-30 50.06 $-4.72 0.00
2022-06-30 59.40 $2.00 29.70
2022-03-31 71.42 $2.09 34.17
2021-12-31 78.81 $2.53 31.15
2021-09-30 73.57 $2.39 30.78
2021-06-30 73.37 $2.19 33.50
2021-03-31 76.60 $2.08 36.83
2020-12-31 72.65 $2.14 33.95
2020-09-30 72.58 $1.76 41.24
2020-06-30 77.49 $1.78 43.53
2020-03-31 72.87 $1.96 37.18
2019-12-31 74.86 $1.98 37.81
2019-09-30 78.10 $2.68 29.14
2019-06-30 72.94 $2.97 24.56
2019-03-31 72.21 $2.94 24.56
2018-12-31 58.30 $2.99 19.50
2018-09-30 68.10 $2.21 30.81
2018-06-30 65.06 $1.66 39.19
2018-03-31 57.15 $1.51 37.85
2017-12-31 56.67 $1.29 43.93
2017-09-30 54.88 $1.86 29.50
2017-06-30 52.81 $1.65 32.00
2017-03-31 45.11 $3.36 13.43
2016-12-31 38.47 $8.99 4.28
2016-09-30 41.18 $8.92 4.62
2016-06-30 39.01 $8.68 4.49
2016-03-31 35.34 $7.09 4.98
2015-12-31 32.72 $1.75 18.70
2015-09-30 28.09 $3.12 9.00
2015-06-30 32.38 $3.98 8.14
2015-03-31 31.72 $4.33 7.33
2014-12-31 33.94 $4.56 7.44
2014-09-30 33.23 $3.41 9.75
2014-06-30 33.48 $3.54 9.46
2014-03-31 34.07 $3.66 9.31
2013-12-31 32.20 $3.65 8.82
2013-09-30 30.42 $3.95 7.70
2013-06-30 32.07 $4.02 7.98
2013-03-31 33.63 $4.14 8.12
2012-12-31 30.87 $4.18 7.38
2012-09-30 27.91 $4.11 6.79
2012-06-30 24.61 $4.06 6.06
2012-03-31 27.68 $3.94 7.03
2011-12-31 22.91 $3.88 5.90
2011-09-30 25.99 $3.78 6.88
2011-06-30 27.64 $3.78 7.31
2011-03-31 24.90 $3.61 6.90
2010-12-31 23.44 $3.49 6.72
2010-09-30 22.09 $3.71 5.95
2010-06-30 18.82 $3.57 5.27
2010-03-31 26.95 $3.63 7.42
2009-12-31 27.17 $3.60 7.55
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $16.278B $10.636B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.364B 28.06
Stryker (SYK) United States $146.969B 30.73
Boston Scientific (BSX) United States $146.968B 36.79
EssilorLuxottica (ESLOY) France $131.277B 0.00
Medtronic (MDT) Ireland $112.813B 15.99
Lonza Group Ag (LZAGY) Switzerland $50.710B 0.00
Haleon (HLN) United Kingdom $49.016B 27.92
ResMed (RMD) United States $37.047B 27.83
Agilent Technologies (A) United States $34.235B 22.32
GE HealthCare Technologies (GEHC) United States $33.847B 16.07
Terumo (TRUMY) Japan $26.946B 35.00
Koninklijke Philips (PHG) Netherlands $22.399B 16.10
Insulet (PODD) United States $21.023B 82.52
Zimmer Biomet Holdings (ZBH) United States $18.780B 12.06
Smith & Nephew SNATS (SNN) United Kingdom $13.165B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Bio-Rad Laboratories (BIO) United States $6.273B 21.83
Lantheus Holdings (LNTH) United States $5.564B 14.03
Prestige Consumer Healthcare (PBH) United States $4.281B 19.13
Perrigo (PRGO) Ireland $3.794B 9.62
Haemonetics (HAE) United States $3.466B 15.79
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.367B 24.83
Envista Holdings (NVST) United States $3.244B 26.96
GN Store Nord (GNNDY) Denmark $2.180B 18.06
QuidelOrtho (QDEL) United States $2.091B 14.38
LeMaitre Vascular (LMAT) United States $1.890B 42.24
AtriCure (ATRC) United States $1.653B 0.00
Acuren (TIC) United States $1.314B 0.00
Neogen (NEOG) United States $1.268B 16.22
AdaptHealth (AHCO) United States $1.190B 12.08
BioLife Solutions (BLFS) United States $1.136B 0.00
Green Thumb Industries (GTBIF) United States $1.063B 23.91
Kestra Medical Technologies (KMTS) United States $1.053B 0.00
Phibro Animal Health (PAHC) United States $0.987B 12.61
InMode (INMD) Israel $0.920B 9.27
CeriBell (CBLL) United States $0.640B 0.00
Evolus (EOLS) United States $0.636B 0.00
Capricor Therapeutics (CAPR) United States $0.634B 0.00
Owens & Minor (OMI) United States $0.629B 5.22
Curaleaf Holdings (CURLF) Canada $0.565B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.550B 0.00
Valneva SE (VALN) France $0.535B 0.00
Tilray Brands (TLRY) Canada $0.422B 0.00
Surmodics (SRDX) United States $0.418B 0.00
VAREX IMAGING (VREX) United States $0.367B 13.50
SNDL (SNDL) Canada $0.347B 0.00
Aurora Cannabis (ACB) Canada $0.334B 59.50
SEMPERIT AG HLD (SEIGY) Austria $0.283B 0.00
Canopy Growth (CGC) Canada $0.276B 0.00
Cerus (CERS) United States $0.275B 0.00
Viemed Healthcare (VMD) United States $0.273B 23.00
ZimVie (ZIMV) United States $0.266B 12.09
Sanara MedTech (SMTI) United States $0.265B 0.00
Sanuwave Health (SNWV) United States $0.264B 0.00
Quanterix (QTRX) United States $0.256B 0.00
Cresco Labs (CRLBF) United States $0.253B 0.00
Omeros (OMER) United States $0.227B 0.00
Biote (BTMD) United States $0.227B 6.37
OraSure Technologies (OSUR) United States $0.224B 0.00
Brainsway (BWAY) Israel $0.216B 57.30
TriSalus Life Sciences (TLSI) United States $0.211B 0.00
Organigram Global (OGI) Canada $0.191B 0.00
High Tide (HITI) Canada $0.188B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.16
Verano Holdings (VRNOF) United States $0.180B 0.00
Exagen (XGN) United States $0.157B 0.00
Vireo Growth (VREOF) United States $0.133B 0.00
FitLife Brands (FTLF) United States $0.131B 16.18
MacroGenics (MGNX) United States $0.112B 0.00
Jin Medical (ZJYL) China $0.105B 0.00
Veru (VERU) United States $0.098B 0.00
Fonar (FONR) United States $0.092B 11.88
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Quipt Home Medical (QIPT) United States $0.090B 0.00
Agape ATP (ATPC) $0.079B 0.00
TerrAscend (TSNDF) Canada $0.074B 0.00
Apyx Medical (APYX) United States $0.069B 0.00
InterCure (INCR) Israel $0.067B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
Zynex (ZYXI) United States $0.066B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
ImmuCell (ICCC) United States $0.057B 0.00
Modular Medical (MODD) United States $0.045B 0.00
Nephros (NEPH) United States $0.041B 55.43
United-Guardian (UG) United States $0.037B 12.94
Rockwell Medical (RMTI) United States $0.035B 0.00
Safety Shot (SHOT) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Cellectar Biosciences (CLRB) United States $0.017B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
INLIF (INLF) $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00